Quantum Chemistry in Drug Design

This track highlights the application of quantum mechanical principles to understand molecular behavior and accelerate drug discovery. It focuses on computational methods such as density functional theory (DFT), quantum molecular simulations, and electronic structure analysis to predict reactivity, binding interactions, and physicochemical properties of drug candidates. By enabling precise modeling of molecular energetics and interactions at the atomic level, quantum chemistry provides deeper insights into lead optimization, reaction mechanisms, and target–ligand binding. The track emphasizes emerging quantum computing tools, hybrid QM/MM approaches, and their growing role in designing more selective and efficient therapeutics.

 

    Related Conference of Quantum Chemistry in Drug Design

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Quantum Chemistry in Drug Design Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in